申请人:Schering Aktiengesellschaft
公开号:US05885548A1
公开(公告)日:1999-03-23
The invention relates to new, multiply substituted diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 or 57-83, pharmaceutical agents that contain these compounds, their use as contrast media and antidotes, and process for the production of pharmaceutical agents.
该发明涉及新的、多取代的乙二胺五乙酸螯合物衍生物,其复合物和复合盐,包含原子序数为20-32、39-51或57-83的元素,含有这些化合物的药物剂,它们作为对比介质和解毒剂的用途,以及制备药物剂的过程。